Akos Czibere Selected Research

sulindac sulfide

7/2012	NSAIDs induce apoptosis in nonproliferating ovarian cancer cells and inhibit tumor growth in vivo.
9/2011	The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.
1/2011	Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akos Czibere Research Topics

Disease

14	Neoplasms (Cancer) 09/2022 - 09/2004
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2015 - 06/2005
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2015 - 06/2005
5	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 08/2011
4	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 01/2011
3	Anemia 10/2020 - 07/2006
2	Multiple Myeloma 03/2024 - 12/2007
2	Disease Progression 01/2021 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 02/2012
2	Melanoma (Melanoma, Malignant) 01/2011 - 12/2006
1	Cytokine Release Syndrome 03/2024
1	Triple Negative Breast Neoplasms 10/2023
1	Adenocarcinoma 01/2021
1	Neutropenia 10/2020
1	Thrombocytopenia (Thrombopenia) 10/2020
1	Nausea 01/2020
1	Vomiting 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Diarrhea 01/2017
1	Carcinogenesis 01/2017
1	Exanthema (Rash) 01/2017
1	Cholangiocarcinoma 01/2017
1	Stomatitis 01/2017
1	Paronychia 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2015
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 05/2013
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2012
1	Leukemia 02/2012
1	Stomach Neoplasms (Stomach Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

8	talazoparibIBA 10/2023 - 01/2020
4	CytokinesIBA 03/2024 - 12/2006
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023 - 01/2021
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2012 - 12/2006
3	PlatinumIBA 10/2023 - 12/2016
3	enzalutamideIBA 09/2022 - 01/2021
3	histidine-rich proteinsIBA 01/2018 - 12/2016
3	seribantumabIBA 01/2017 - 12/2016
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2004
3	sulindac sulfideIBA 07/2012 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 12/2016
2	ProteomeIBA 05/2013 - 01/2007
2	Diclofenac (SR 38)FDA LinkGeneric 09/2011 - 01/2011
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2011 - 08/2011
2	Phosphotransferases (Kinase)IBA 08/2011 - 12/2006
2	Small Interfering RNA (siRNA)IBA 08/2011 - 09/2004
2	JNK Mitogen-Activated Protein KinasesIBA 08/2011 - 09/2004
2	InterleukinsIBA 01/2011 - 12/2006
2	sulindac sulfone (exisulind)IBA 11/2006 - 06/2005
1	Chimeric Antigen ReceptorsIBA 03/2024
1	Bispecific AntibodiesIBA 03/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024
1	B-Cell Maturation AntigenIBA 03/2024
1	AnthracyclinesIBA 10/2023
1	Testosterone (Sustanon)FDA Link 09/2022
1	DNA (Deoxyribonucleic Acid)IBA 09/2022
1	Androgen Receptors (Androgen Receptor)IBA 02/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	taxaneIBA 01/2021
1	abirateroneIBA 01/2021
1	IstiratumabIBA 01/2018
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Neuregulin-1 (Neuregulin 1)IBA 01/2018
1	Insulin-Like PeptidesIBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2018
1	Hormones (Hormone)IBA 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017
1	Azacitidine (5 Azacytidine)FDA Link 04/2015
1	CalciumIBA 05/2013
1	IntegrinsIBA 05/2013
1	Fibrinogen (Factor I)FDA Link 05/2013
1	Flurbiprofen (Froben)FDA LinkGeneric 07/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2012
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2012
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2012
1	(5- fluoro- 2- methyl- 1- (4- pyridyl)methylene- 3- (N- benzyl)- indene)- acetamide hydrochlorideIBA 02/2012
1	Interleukin-6 (Interleukin 6)IBA 08/2011
1	Transcription Factors (Transcription Factor)IBA 01/2011
1	Sorafenib (BAY 43-9006)FDA Link 01/2010
1	ribosomal protein S14IBA 10/2009
1	Bortezomib (Velcade)FDA Link 12/2007
1	Bendamustine Hydrochloride FDA Link 12/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2007

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 10/2023 - 09/2004
6	Therapeutics 02/2022 - 12/2007
3	Castration 09/2022 - 01/2021
3	Stem Cell Transplantation 04/2015 - 07/2007
1	Immunotherapy 03/2024
1	Neoadjuvant Therapy 10/2023
1	Salvage Therapy 04/2015
1	Hematopoietic Stem Cell Transplantation 04/2015
1	Withholding Treatment 02/2012